Pmv Pharmaceuticals, Inc
Clinical trials sponsored by Pmv Pharmaceuticals, Inc, explained in plain language.
-
New drug targets rare cancer mutation in 300-patient trial
Disease control Recruiting nowThis study tests a new drug called PC14586 (rezatapopt) in people with advanced or spreading solid tumors that have a specific change in the TP53 gene (Y220C mutation). The goal is to see if the drug is safe and works against these cancers. About 300 adults (and some teens after …
Phase: PHASE1, PHASE2 • Sponsor: PMV Pharmaceuticals, Inc • Aim: Disease control
Last updated May 16, 2026 23:47 UTC
-
New cancer drug's effect on common meds tested in small early study
Knowledge-focused Recruiting nowThis early-phase study looks at how a new drug called rezatapopt affects the way the body processes four common medicines (metformin, rosuvastatin, repaglinide, and midazolam) in people with advanced solid tumors that have a specific TP53 Y220C mutation. About 14 participants wil…
Phase: PHASE1 • Sponsor: PMV Pharmaceuticals, Inc • Aim: Knowledge-focused
Last updated May 14, 2026 12:04 UTC